Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.

导出 LinkOut

翻译打印收藏纠错

第一作者： S F,Jørgensen

第一单位： Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway. s.f.jorgensen@medisin.uio.no.

作者： S F,Jørgensen ^[1] ; M E,Macpherson ^[2] ; T,Bjørnetrø ^[3] ; K,Holm ^[4] ; M,Kummen ^[5] ; A,Rashidi ^[6] ; A E,Michelsen ^[4] ; T,Lekva ^[7] ; B,Halvorsen ^[4] ; M,Trøseid ^[6] ; T E,Mollnes ^[7] ; R K,Berge ^[4] ; A,Yndestad ^[7] ; T,Ueland ^[4] ; T H,Karlsen ^[4] ; P,Aukrust ^[6] ; J R,Hov ^[4] ; B,Fevang ^[4]

作者单位： Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway. s.f.jorgensen@medisin.uio.no. ^[1] Section of Clinical Immunology and Infectious Diseases, Department of Rheumatology, Dermatology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, Norway. s.f.jorgensen@medisin.uio.no. ^[2] Institute of Clinical Medicine, University of Oslo, Oslo, Norway. s.f.jorgensen@medisin.uio.no. ^[3] Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Norway. ^[4] Section of Clinical Immunology and Infectious Diseases, Department of Rheumatology, Dermatology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, Norway. ^[5] Institute of Clinical Medicine, University of Oslo, Oslo, Norway. ^[6] Norwegian PSC Research Center, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway. ^[7] Research Laboratory, Nordland Hospital, Bodø, and Faculty of Health Sciences, K.G. Jebsen TREC, University of Tromsø, Tromsø, Norway. ^[8] Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway. ^[9] Department of Immunology, Oslo University Hospital, and University of Oslo, Oslo, Norway. ^[10] Department of Clinical Science, University of Bergen, Bergen, Norway. ^[11] Department of Heart Disease, Haukeland University Hospital, Bergen, Norway. ^[12]

DOI 10.1038/s41598-024-54117-6

PMID 38355714

发布时间 2024-02-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Scientific reports

2024年14卷1期

3704页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.

Scientific reports

相似文献

Scientific reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.

Scientific reports

相似文献

Scientific reports

相关期刊

检索历史清除